Key Findings from GAO Report on Orphan Drug Approval Modernization
This article was originally published at https://www.drugpatentwatch.com/blog/key-findings-from-gao-report-on-orphan-drug-approval-modernization/
In November 2018, the Government Accountability Office (GAO) released a report titled “FDA Could Improve Designation Review Consistency; Rare Disease Drug Development Challenges Continue.” It follows up on the FDA’s Orphan… The post Key Findings from GAO Report on Orphan Drug Approval Modernization appeared first on DrugPatentWatch - Make Better Decisions.Comments are closed.